{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:19:58Z","timestamp":1776259198253,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["179884"],"award-info":[{"award-number":["179884"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>During the COVID-19 pandemic, operating room restrictions led to triaging of breast cancer (BC) surgery. This study assessed the impact of the pandemic on wait times for BC surgery at a population level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients diagnosed with BC between January 2018 and December 2021 in Ontario, Canada, were categorized as pre-pandemic (January 1, 2018, to March 14, 2020), immediate (March 15, 2020, to June 13, 2020), and peri-pandemic (June 14, 2020, to December 31, 2021). Time-to-event analysis evaluated the time to first BC surgery, with subgroup analyses for patients receiving neoadjuvant chemotherapy (NAC) and neoadjuvant endocrine therapy (NET).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 37,520 patients with newly diagnosed BC, the probability of undergoing surgery each month from their diagnosis date was significantly lower during the immediate and peri-pandemic period than during the pre-pandemic period (log-rank\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.01). However, the use of NAC and NET increased during the immediate pandemic compared with the pre-pandemic (NAC: 24.3% vs. 14.4%; NET 12.4% vs. 6.6%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.01). Among patients who had surgery as first treatment, the median wait time was shortest during the immediate pandemic (1.0 mo) compared with the pre- and peri-pandemic periods (1.2 mo,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This population-based study found longer diagnosis-to-surgery times during the immediate pandemic, with increased use of neoadjuvant therapy. However, surgical wait times (e.g. post NAC) were shorter in the immediate pandemic, highlighting the triaging of BC care during this unprecedented event.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-19029-3","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T23:18:28Z","timestamp":1769296708000},"page":"4472-4481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Breast Cancer Surgery Wait Times and COVID-19: A Canadian Population-Based Analysis"],"prefix":"10.1245","volume":"33","author":[{"given":"Gary","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitan","family":"Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M.","family":"Covelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivianne","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Anne","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenine","family":"Ramruthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Reel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulin D.","family":"Cil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"19029_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106586","volume":"151","author":"MJ Walker","year":"2021","unstructured":"Walker MJ, Meggetto O, Gao J, et al. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: a provincial, population-based study. Prev Med. 2021;151:106586. https:\/\/doi.org\/10.1016\/j.ypmed.2021.106586.","journal-title":"Prev Med."},{"key":"19029_CR2","unstructured":"Pandemic planning clinical guideline for patients with cancer."},{"issue":"3","key":"19029_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3747\/co.27.6699","volume":"27","author":"D Berger-Richardson","year":"2020","unstructured":"Berger-Richardson D, Ko G, Hong NJL. Preparing for the renaissance: treating breast cancer during the COVID-19 pandemic and planning for a safe re-emergence to routine surgical care within a universal health care system. Curr Oncol. 2020;27(3):163\u20138. https:\/\/doi.org\/10.3747\/co.27.6699.","journal-title":"Curr Oncol."},{"issue":"3","key":"19029_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-020-05644-z","volume":"181","author":"JR Dietz","year":"2020","unstructured":"Dietz JR, Moran MS, Isakoff SJ, et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020;181(3):487\u201397. https:\/\/doi.org\/10.1007\/s10549-020-05644-z.","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"19029_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2015.4508.","journal-title":"JAMA Oncol."},{"issue":"5","key":"19029_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jamasurg.2022.8388","volume":"158","author":"AA Wiener","year":"2023","unstructured":"Wiener AA, Hanlon BM, Schumacher JR, Vande Walle KA, Wilke LG, Neuman HB. Reexamining time from breast cancer diagnosis to primary breast surgery. JAMA Surgery. 2023;158(5):485\u201392. https:\/\/doi.org\/10.1001\/jamasurg.2022.8388.","journal-title":"JAMA Surgery."},{"issue":"2","key":"19029_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.amjsurg.2020.12.015","volume":"222","author":"BA Johnson","year":"2021","unstructured":"Johnson BA, Waddimba AC, Ogola GO, Fleshman JW, Preskitt JT. A systematic review and meta-analysis of surgery delays and survival in breast, lung and colon cancers: Implication for surgical triage during the COVID-19 pandemic. Am J Surg. 2021;222(2):311\u20138. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.12.015.","journal-title":"Am J Surg."},{"issue":"7","key":"19029_CR8","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.ejso.2021.01.025","volume":"47","author":"C Cullinane","year":"2021","unstructured":"Cullinane C, Shrestha A, Al Maksoud A, et al. Optimal timing of surgery following breast cancer neoadjuvant chemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol. 2021;47(7):1507\u201313. https:\/\/doi.org\/10.1016\/j.ejso.2021.01.025.","journal-title":"Eur J Surg Oncol."},{"issue":"10","key":"19029_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, et al. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. https:\/\/doi.org\/10.1371\/journal.pmed.1001885.","journal-title":"PLoS Med."},{"key":"19029_CR10","unstructured":"Iron K, Zagorski B, Sykora K, Manuel D. Living and dying in ontario: an opportunity for improved health information. Institute for clinical evaluative sciences. Available from; https:\/\/www.ices.on.ca\/publications\/research-reports\/living-and-dying-in-ontario-an-opportunity-to-improve-health-information\/"},{"key":"19029_CR11","unstructured":"DM_OH_CMOH_memo_COVID19_elective_surgery_March_15_2020.pdf. Ramping down elective surgeries and other non-emergent activities [memorandum to Ontario Health and hospitals]. Accessed September 15, 2025. https:\/\/www.health.gov.on.ca\/en\/pro\/programs\/publichealth\/coronavirus\/docs\/memos\/DM_OH_CMOH_memo_COVID19_elective_surgery_March_15_2020.pdf"},{"key":"19029_CR12","unstructured":"Ministry of Health. COVID-19 Operational requirements: health sector restart. June 15, 2020. Accessed September 15, 2025. https:\/\/www.health.gov.on.ca\/en\/pro\/programs\/publichealth\/coronavirus\/docs\/operational_requirements_health_sector.pdf"},{"issue":"2","key":"19029_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10549-020-06008-3","volume":"186","author":"L Cadili","year":"2021","unstructured":"Cadili L, DeGirolamo K, McKevitt E, et al. COVID-19 and breast cancer at a regional breast centre: our flexible approach during the pandemic. Breast Cancer Res Treat. 2021;186(2):519\u201325. https:\/\/doi.org\/10.1007\/s10549-020-06008-3.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"19029_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-025-07617-6","volume":"211","author":"ML Fefferman","year":"2025","unstructured":"Fefferman ML, Chan K, Cotler J, et al. Did the COVID-19 consortium recommendations impact the treatment of breast cancer during the COVID-19 pandemic? Breast Cancer Res Treat. 2025;211(1):11\u201322. https:\/\/doi.org\/10.1007\/s10549-025-07617-6.","journal-title":"Breast Cancer Res Treat."},{"issue":"11","key":"19029_CR15","doi-asserted-by":"publisher","first-page":"E408","DOI":"10.1503\/cmaj.202380","volume":"194","author":"A Parmar","year":"2022","unstructured":"Parmar A, Eskander A, Sander B, Naimark D, Irish JC, Chan KKW. Impact of cancer surgery slowdowns on patient survival during the COVID-19 pandemic: a microsimulation modelling study. CMAJ. 2022;194(11):E408\u201314. https:\/\/doi.org\/10.1503\/cmaj.202380.","journal-title":"CMAJ."},{"issue":"8","key":"19029_CR16","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1245\/s10434-016-5128-0","volume":"23","author":"E Cordeiro","year":"2016","unstructured":"Cordeiro E, Jackson T, Cil T. Same-day major breast cancer surgery is safe: an analysis of short-term outcomes using NSQIP data. Ann Surg Oncol. 2016;23(8):2480\u20136. https:\/\/doi.org\/10.1245\/s10434-016-5128-0.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"19029_CR17","doi-asserted-by":"publisher","first-page":"683e","DOI":"10.1097\/PRS.0000000000010822","volume":"153","author":"A Miller","year":"2024","unstructured":"Miller A, Jain NS, Wells MW, et al. Same-day discharge for immediate breast reconstruction: a national surgical quality improvement program study. Plast Reconstr Surg. 2024;153(4):683e\u20139e. https:\/\/doi.org\/10.1097\/PRS.0000000000010822.","journal-title":"Plast Reconstr Surg."},{"issue":"7","key":"19029_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000005183","volume":"11","author":"AT Mohan","year":"2023","unstructured":"Mohan AT, MacArthur TA, Murphy B, et al. Patient experience and clinical outcomes after same-day outpatient mastectomy and immediate breast reconstruction protocol during the global pandemic. Plast Reconstr Surg Glob Open. 2023;11(7):e5183. https:\/\/doi.org\/10.1097\/GOX.0000000000005183.","journal-title":"Plast Reconstr Surg Glob Open."},{"issue":"4","key":"19029_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12630-021-02182-0","volume":"69","author":"A Clairoux","year":"2022","unstructured":"Clairoux A, Soucy-Proulx M, Pretto F, et al. Intrapandemic regional anesthesia as practice: a historical cohort study in patients undergoing breast cancer surgery. Can J Anaesth. 2022;69(4):485\u201393. https:\/\/doi.org\/10.1007\/s12630-021-02182-0.","journal-title":"Can J Anaesth."},{"key":"19029_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103689","volume":"74","author":"A Hatchell","year":"2024","unstructured":"Hatchell A, Osman M, Bielesch J, Temple-Oberle C. Acceptance of outpatient enhanced recovery after surgery (ERAS\u00a9) protocols for implant-based breast reconstruction nudged on by the COVID-19 pandemic. Breast. 2024;74:103689. https:\/\/doi.org\/10.1016\/j.breast.2024.103689.","journal-title":"Breast."},{"issue":"6","key":"19029_CR21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/ans.18901","volume":"94","author":"J Mui","year":"2024","unstructured":"Mui J, Cheng E, Salindera S. Enhanced recovery after surgery for oncological breast surgery reduces length of stay in a resource limited setting. ANZ J Surg. 2024;94(6):1096\u2013101. https:\/\/doi.org\/10.1111\/ans.18901.","journal-title":"ANZ J Surg."},{"issue":"9","key":"19029_CR22","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/j.1365-2648.2011.05638.x","volume":"67","author":"S Drageset","year":"2011","unstructured":"Drageset S, Lindstr\u00f8m TC, Giske T, Underlid K. Being in suspense: women\u2019s experiences awaiting breast cancer surgery: women\u2019s experiences awaiting breast cancer surgery. J Adv Nurs. 2011;67(9):1941\u201351. https:\/\/doi.org\/10.1111\/j.1365-2648.2011.05638.x.","journal-title":"J Adv Nurs."},{"issue":"3","key":"19029_CR23","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1245\/s10434-021-11209-1","volume":"29","author":"A Ludwigson","year":"2021","unstructured":"Ludwigson A, Huynh V, Myers S, et al. Patient perceptions of changes in breast cancer care and well-being during COVID-19: a mixed methods study. Ann Surg Oncol. 2021;29(3):1649. https:\/\/doi.org\/10.1245\/s10434-021-11209-1.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"19029_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10549-024-07547-9","volume":"210","author":"G Ko","year":"2025","unstructured":"Ko G, Li Q, Liu N, et al. Impact of the COVID-19 pandemic on breast cancer surgeries in a Canadian population. Breast Cancer Res Treat. 2025;210(1):147\u201356. https:\/\/doi.org\/10.1007\/s10549-024-07547-9.","journal-title":"Breast Cancer Res Treat."},{"issue":"10","key":"19029_CR25","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1245\/s10434-021-10639-1","volume":"28","author":"LG Wilke","year":"2021","unstructured":"Wilke LG, Nguyen TT, Yang Q, et al. Analysis of the impact of the COVID-19 pandemic on the multidisciplinary management of breast cancer: review from the american society of breast surgeons COVID-19 and mastery registries. Ann Surg Oncol. 2021;28(10):5535\u201343. https:\/\/doi.org\/10.1245\/s10434-021-10639-1.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"19029_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25118","volume":"5","author":"S Habbous","year":"2022","unstructured":"Habbous S, Tai X, Beca JM, et al. Comparison of use of neoadjuvant systemic treatment for breast cancer and short-term outcomes before versus during the COVID-19 era in Ontario, Canada. JAMA Netw Open. 2022;5(8):e2225118. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.25118.","journal-title":"JAMA Netw Open."},{"issue":"6","key":"19029_CR27","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3390\/cancers12061578","volume":"12","author":"M\u00c1 L\u00f3pez-Garc\u00eda","year":"2020","unstructured":"L\u00f3pez-Garc\u00eda M\u00c1, Carretero-Barrio I, P\u00e9rez-M\u00edes B, et al. Low prevalence of HER2-positive breast carcinomas among screening detected breast cancers. Cancers. 2020;12(6):1578. https:\/\/doi.org\/10.3390\/cancers12061578.","journal-title":"Cancers."},{"issue":"1","key":"19029_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-022-06522-6","volume":"193","author":"S Gandhi","year":"2022","unstructured":"Gandhi S, Brackstone M, Hong NJL, et al. A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles. Breast Cancer Res Treat. 2022;193(1):1\u201320. https:\/\/doi.org\/10.1007\/s10549-022-06522-6.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"19029_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1245\/s10434-022-12491-3","volume":"30","author":"N Escobar","year":"2023","unstructured":"Escobar N, DiMaggio C, Pocock B, Pescovitz A, McCalla S, Joseph KA. Effects of COVID-19 on surgical delays in patients with breast cancer in NYC public hospitals: a multicenter study. Ann Surg Oncol. 2023;30(1):23\u201330. https:\/\/doi.org\/10.1245\/s10434-022-12491-3.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19029-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-19029-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19029-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:26:07Z","timestamp":1776255967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-19029-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["19029"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-19029-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is a revised and expanded version of the following conference abstracts entitled \u201cDelays in breast cancer surgery during the COVID-19 pandemic: A population-based analysis\u201d presented as posters during the following meetings: San Antonio Breast Cancer Symposium, San Antonio, December 2023. Ko G, Roberts A, Li Q, Liu N, Zhong T, Amir E, Koch A, Covelli A, Freitas V, Reel E, Eskander A. Delays in breast cancer surgery during the COVID-19 pandemic: A population-based analysis. In: Proceedings of the American Association for Cancer Research (AACR) Annual Meeting, San Diego, CA, USA, April 2024. Cancer Res. 2024;84(9_Suppl):PO3-23-02.\n                      \n                      . Society of Surgical Oncology Annual Meeting, Atlanta, Georgia, USA, 2024. Society of Surgical Oncology SSO 2024 Annual Meeting. Ann Surg Oncol 2024;31(Suppl 1):1\u2013294.\n                      \n                      . Dr. Eitan Amir reports receiving honoraria from Seagen, Gilead, Pfizer, and\u00a0AstraZeneca. Additional honoraria were directed to his institution from Novartis. He has served in a consulting or advisory role for AstraZeneca and Novartis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The study was approved by the Research Ethics Board of University Health Network, Toronto, Canada (22-5809) on December 8, 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Due to the retrospective nature of the study, formal consent was not required, as per the guidelines of Research Ethics Board of University Health Network, Toronto, Canada and in accordance with ICES policies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}